Medifast MED Optavia Segment — Nonoperating Income (Expense)

Similar metrics at other companies

CHE

CHESegment Vitas — Nonoperating Income Expense

$95K+97.9%

INSPOperating Segment — Nonoperating Income (Expense)

$3.52M-37.7%

UNHOptum — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

$3.3B-15.3%

CHE

CHESegment Vitas — Other Operating Income Expense Net

-$52K+18.8%

OGEAll Other Segments — Other Nonoperating Income Expense

-$300K-125%

BTCSAll Other Segments — Nonoperating Income Expense

-$1.55M-787%

Questions, answered.

What is Medifast's optavia segment — nonoperating income (expense)?

Medifast (MED) reported optavia segment — nonoperating income (expense) of $1.35M in Q1 2026.

How has Medifast's optavia segment — nonoperating income (expense) changed year-over-year?

Medifast's optavia segment — nonoperating income (expense) decreased by 24.3% year-over-year, from $1.79M to $1.35M.

What is the long-term trend for Medifast's optavia segment — nonoperating income (expense)?

Over 3 years (2022 to 2025), Medifast's optavia segment — nonoperating income (expense) has grown at a 125.6% compound annual growth rate (CAGR), from -$747K to $8.57M.

What does optavia segment — nonoperating income (expense) mean?

Includes financial activities outside of the core Optavia business operations, such as interest income, interest expense, or gains/losses on investments. It provides a view of the segment's financial health independent of its primary product sales.